Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease
- PMID: 16601919
- DOI: 10.1007/s00198-006-0091-4
Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease
Abstract
Introduction: Although it has been established that hyperthyroidism leads to reduced bone mineral density (BMD), with accelerated bone turnover promoting bone resorption in female patients, there is a dearth of data for male patients with hyperthyroidism. This study evaluated BMD and bone metabolism in male patients with Graves' disease.
Methods: The study included 56 Japanese male patients with newly diagnosed Graves' disease and 34 normal Japanese male control subjects of similar age and body mass index. We used dual energy x-ray absorptiometry to measure BMD at sites with different cortical/cancellous bone ratios (lumbar spine, femoral neck, and distal radius).
Results: At the lumbar spine and the distal radius, BMD and T-scores were significantly lower for patients than for controls. At the femoral neck, on the other hand, the same values were relatively, but not significantly, lower in patients than in controls. However, Z-scores at all three sites were significantly lower for patients than for controls. The Z -score at the distal radius of patients was significantly lower than that at their lumbar spine and femoral neck. In addition, Z-score at the distal radius correlated negatively with age, free thyroxine, thyroid stimulating hormone receptor antibodies, thyroid stimulating antibody, and urinary N-terminal telopeptide of type I collagen normalized by creatinine.
Conclusions: These results indicate a high prevalence of cortical bone loss in male patients with Graves' disease, especially elderly patients. We conclude that BMD measurement is crucial in all Graves' disease patients regardless of their gender and that the radial BMD as well as BMD at the lumbar spine and femoral neck should be monitored to effectively prevent bone loss and subsequent fracture.
Similar articles
-
IMPACT OF GRAVES' DISEASE AND ANTITHYROID DRUG THERAPY ON BONE MINERAL DENSITY - PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL RELEVANCE.Acta Clin Croat. 2022 Nov;61(3):496-504. doi: 10.20471/acc.2022.61.03.15. Acta Clin Croat. 2022. PMID: 37492357 Free PMC article. Review.
-
The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.J Investig Med. 2013 Jun;61(5):842-7. doi: 10.2310/JIM.0b013e31828fcafb. J Investig Med. 2013. PMID: 23612147
-
TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.Arch Endocrinol Metab. 2018 Mar-Apr;62(2):221-226. doi: 10.20945/2359-3997000000027. Arch Endocrinol Metab. 2018. PMID: 29768627 Free PMC article.
-
Low Bone Mineral Density at Initial Diagnosis in Children and Adolescents with Graves' Disease.J Clin Densitom. 2021 Apr-Jun;24(2):275-280. doi: 10.1016/j.jocd.2020.05.006. Epub 2020 May 21. J Clin Densitom. 2021. PMID: 32546346
-
[Graves' disease and bone metabolism].Nihon Rinsho. 2006 Dec;64(12):2317-22. Nihon Rinsho. 2006. PMID: 17154099 Review. Japanese.
Cited by
-
Association between thymic hyperplasia and serum calcium level in Graves' disease.BMC Endocr Disord. 2024 Jan 29;24(1):15. doi: 10.1186/s12902-024-01541-4. BMC Endocr Disord. 2024. PMID: 38281931 Free PMC article.
-
IMPACT OF GRAVES' DISEASE AND ANTITHYROID DRUG THERAPY ON BONE MINERAL DENSITY - PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL RELEVANCE.Acta Clin Croat. 2022 Nov;61(3):496-504. doi: 10.20471/acc.2022.61.03.15. Acta Clin Croat. 2022. PMID: 37492357 Free PMC article. Review.
-
Association between calcaneus quantitative ultrasound (QUS) parameters and thyroid status in middle-aged and elderly Chinese men with euthyroidism: a population-based cross-sectional study.Endocrine. 2014 Sep;47(1):227-33. doi: 10.1007/s12020-013-0147-0. Epub 2014 Jan 24. Endocrine. 2014. PMID: 24464689
-
Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.Thyroid Res. 2013 Sep 11;6(1):11. doi: 10.1186/1756-6614-6-11. Thyroid Res. 2013. PMID: 24020400 Free PMC article.
-
Hyperthyroidism and Wnt Signaling Pathway: Influence on Bone Remodeling.Metabolites. 2023 Feb 6;13(2):241. doi: 10.3390/metabo13020241. Metabolites. 2023. PMID: 36837860 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical